Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by expansion of unstable CTG repeats in a non-coding region of the DMPK gene. CUG expansions in mutant DMPK transcripts sequester MBNL1 proteins in ribonuclear foci. Depletion of this protein is a primary contributor to disease s...
Հիմնական հեղինակներ: | Cerro-Herreros, E, González-Martínez, I, Moreno, N, Espinosa-Espinosa, J, Fernández-Costa, JM, Colom-Rodrigo, A, Overby, SJ, Seoane-Miraz, D, Poyatos-García, J, Vilchez, JJ, López de Munain, A, Varela, MA, Wood, MJ, Pérez-Alonso, M, Llamusí, B, Artero, R |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Cell Press
2021
|
Նմանատիպ նյութեր
-
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
: Estefanía Cerro-Herreros, և այլն
Հրապարակվել է: (2021-12-01) -
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
: Estefanía Cerro-Herreros, և այլն
Հրապարակվել է: (2020-09-01) -
Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
: Overby, SJ, և այլն
Հրապարակվել է: (2022) -
miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models
: Estefania Cerro-Herreros, և այլն
Հրապարակվել է: (2018-06-01) -
Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes
: Estefania Cerro-Herreros, և այլն
Հրապարակվել է: (2017-06-01)